Healthy adults
Conditions
Interventions
Daily ingestion 60 g of the retort pouch potatoes-1 for 8 weeks.
Daily ingestion 60 g of the retort pouch potatoes-2 for 8 weeks.
Sponsors
Hokkaido Information University
Sapporo Medical University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Subjects who agree to participate in this study with a written informed consent. 2. Subjects with a minor health complaints.
Exclusion criteria
Exclusion criteria: 1. Subjects who participated in UMIN000038876 and/or UMIN000041162. 2. Subjects who are under physician's advice, treatment, and/or medication for schizophrenia, depression, mania, neurological disorders, and/or sleep disorders. 3. Subjects who are under physician's advice, treatment and/or medication for diabetes. 4. Subjects with implantable electronic medical devices. 5. Subjects with serious cerebrovascular, cardiac, hepatic, renal, gastrointestinal diseases, and/or affected with infectious diseases requiring reports to the authorities. 6. Subjects with major surgical history relevant to the digestive system such as gastrectomy, gastrorrhaphy, enterectomy, etc. 7. Subjects with unusually high and/or low blood pressure and/or abnormal hematological data. 8. Subjects with severe anemia. 9. Pre- or post-menopausal women complaining of obvious physical changes. 10. Subjects who are at risk of having allergic reactions to drugs or foods especially based on potatoes, tomatoes, Betulaceae, Poaceae. 11. Subjects who regularly take medicine, functional foods, and/or supplements which would affect sleep and/or stress. 12. Heavy smokers, alcohol addicts or subjects with disordered lifestyle. 13. Subjects who donated either 400 ml whole blood within 16 wks (women), 12 wks (men), 200 ml whole blood within 4 wks, or blood components within 2 wks, prior to the current study. 14. Pregnant or lactating women or women who expect to be pregnant during this study. 15. Subjects who currently participate in other clinical trials, or participated within the last 4 wks prior to the current study. 16. Any other medical and/or health reasons unfavorable to participation in the current study, as judged by the principal investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Peripheral blood test and The Brief Job Stress Questionnaire (Section B) after 8 weeks of ingestion. | — |
Secondary
| Measure | Time frame |
|---|---|
| Heart rate variability, electroencephalogram during sleeping, sleeping record, survey on subjects' sleeping and mental and physical conditions, urinary 8-OHdG, VAS questionnaire assessed fatigue. | — |
Countries
Japan
Contacts
Public ContactNaoyuki HONMA
Hokkaido Information University Health Information Science Center
Outcome results
None listed